Prestige Biologics Statistics

Total Valuation

KOSDAQ:334970 has a market cap or net worth of KRW 251.53 billion. The enterprise value is 339.87 billion.

Market Cap	251.53B
Enterprise Value	339.87B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:334970 has 77.75 million shares outstanding. The number of shares has increased by 27.53% in one year.

Current Share Class	77.75M
Shares Outstanding	77.75M
Shares Change (YoY)	+27.53%
Shares Change (QoQ)	+0.47%
Owned by Insiders (%)	20.30%
Owned by Institutions (%)	0.07%
Float	27.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.83
PB Ratio	2.06
P/TBV Ratio	2.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.03
EV / Sales	25.44
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.10

Financial Position

The company has a current ratio of 0.35, with a Debt / Equity ratio of 0.76.

Current Ratio	0.35
Quick Ratio	0.05
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	-8.25
Interest Coverage	-4.59

Financial Efficiency

Return on equity (ROE) is -24.43% and return on invested capital (ROIC) is -9.98%.

Return on Equity (ROE)	-24.43%
Return on Assets (ROA)	-7.85%
Return on Invested Capital (ROIC)	-9.98%
Return on Capital Employed (ROCE)	-24.94%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.04
Inventory Turnover	1.06

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.17% in the last 52 weeks. The beta is 0.85, so KOSDAQ:334970's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-41.17%
50-Day Moving Average	3,138.00
200-Day Moving Average	3,759.08
Relative Strength Index (RSI)	60.93
Average Volume (20 Days)	141,707

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:334970 had revenue of KRW 13.36 billion and -33.88 billion in losses. Loss per share was -434.46.

Revenue	13.36B
Gross Profit	-12.53B
Operating Income	-37.97B
Pretax Income	-33.88B
Net Income	-33.88B
EBITDA	-24.29B
EBIT	-37.97B
Loss Per Share	-434.46

Full Income Statement

Balance Sheet

The company has 4.76 billion in cash and 93.10 billion in debt, giving a net cash position of -88.34 billion or -1,136.23 per share.

Cash & Cash Equivalents	4.76B
Total Debt	93.10B
Net Cash	-88.34B
Net Cash Per Share	-1,136.23
Equity (Book Value)	122.27B
Book Value Per Share	1,569.77
Working Capital	-76.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.09 billion and capital expenditures -6.20 billion, giving a free cash flow of -11.29 billion.

Operating Cash Flow	-5.09B
Capital Expenditures	-6.20B
Free Cash Flow	-11.29B
FCF Per Share	-145.21

Full Cash Flow Statement

Margins

Gross margin is -93.78%, with operating and profit margins of -284.21% and -253.61%.

Gross Margin	-93.78%
Operating Margin	-284.21%
Pretax Margin	-253.61%
Profit Margin	-253.61%
EBITDA Margin	-181.80%
EBIT Margin	-284.21%
FCF Margin	n/a

Dividends & Yields

KOSDAQ:334970 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.53%
Shareholder Yield	-27.53%
Earnings Yield	-13.47%
FCF Yield	-4.49%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KOSDAQ:334970 has an Altman Z-Score of -0.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.7
Piotroski F-Score	3